Publications

  • How to Make Your Drug Launch A Success

    October 23, 2017 | IN VIVO

    The pain is becoming all too common for many pharmaceutical executives. After a decade or more of investment in drug development and clinical trials, a company launches a promising new product only to see sales fall far short of expectations.

  • How to Make Your Drug Launch a Success

    September 06, 2017 | Pharmaceuticals | Bain Brief

    Bain research shows successful pharmaceutical companies are overhauling their approach to drug launch—and they do three things right.

  • Global Healthcare Private Equity and Corporate M&A Report 2017

    April 19, 2017 | Bain report

    Private equity investors latched onto healthcare as a safe haven in 2016, pushing total deal value to its highest level since 2007.

  • Reinventing the Role of Medical Affairs

    March 15, 2017 | Bain Brief

    A strategic overhaul of medical affairs can help pharma companies win in an era of Big Data medicine.

  • Bayer’s Euphoria Around New Cancer Medicine Meets Skepticism

    October 18, 2016 | Healthcare | Bloomberg | Media mention

    Large pharmaceutical companies are feeling the pressure from competition with newer pharma companies, particularly in the experimental drug pipelines. These newcomers are gaining footholds in these verticals by building market share in one or two types of tumors or focusing on a technology that can

  • Front Line of Healthcare Report 2016: The Shifting European Healthcare Landscape By the Numbers

    September 28, 2016 | Bain report

    For those providing services on the front line of healthcare in Europe, change is accelerating—and there’s no turning back. Digital technologies, cost pressure and tighter protocols are transforming care delivery.

  • Winning Companies Invest in Healthy Life Years

    July 27, 2016 | Bain Brief

    When literacy rates became a useful predictor of a nation’s economic prospects, the world changed. Societies realized that investing in education not only improved the lives of their citizens, it also lifted GDP, and governments got on board. Something similar is happening with healthy living.

  • A Digital Prescription for the Pharma Industry

    June 09, 2016 | Pharma Executive

    The profound shift to electronic medical records and treatment protocols has pharmaceutical companies pouring money into digital tools and initiatives to keep up. But a significant portion of these investments are wasted.

  • Bain: private equity firms circling speciality pharma

    March 15, 2016 | Private Equity | Private Healthcare Investor | Media mention

    Bain & Company Partner Christian Mazzi believes the specialty generic pharmaceutical space is now one of the hottest "here and now" themes for private equity firms. Mazzi, who leads Bain's London Healthcare practice, told Private Healthcare Investor that specialist generic firms have traditionally

  • Getting the Dose Right: A Digital Prescription for the Pharma Industry

    December 16, 2015 | Bain Brief

    Many pharma companies feel overwhelmed by noise about the coming digital transformation. Digital tools and data will enable faster, cheaper, and more effective approaches to drug R&D, production and commercialization - but only for those that create a clear digital strategy.